Skip to main content
Caplight Logo









Keliomics

Keliomics

Private
New Orleans, LouisianaHealthcare & Life Scienceshttps://keliomics.com/

Last Round

Grant

Jan 8, 2024

Total Funding Raised

$1M

Company Overview

Keliomics is a biotechnology company that provides a micro physiological system designed for solid tumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

ex vivo cancer modelsmicro-physiological systemsolid tumor modelsorgan-on-a-chippharmacophenotypingtumoroidspreclinical CROtumor microenvironmentpre-clinical researchorganoid modelsdrug discoveryprecision medicinecancer treatment disparitiesSBIRSmall Business Innovation Research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Keliomics Comparables

Compare Keliomics with similar companies based on industry and business-model similarity.

Keliomics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Xilis
88%
Carcinotech
81%
Hesperos Inc.
80%

Keliomics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 8, 2024
SeedOct 1, 2023
AngelMay 1, 2023

Key People

Founding team and executive leadership

Smriti Agrawal

Co-Founder and Chief Commercial Officer

Founding Team

Keliomics Investors

Notable investors and investment history

Keliomics investors
InvestorRounds
National Cancer InstituteGrant
IdeashipAngel
ONAMIAngel

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 11, 2024

    Grew 27% QoQ, from 11 to 14 employees.

  • Jan 8, 2024

    $400K grant from the National Cancer Institute.

Keliomics Filings

Explore SEC and related filing metadata, where available.

Keliomics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Keliomics's valuation, stock price, and market status.

Is Keliomics a public or private company?

Keliomics is a private company.

What is the current stock price of Keliomics?

Keliomics is a private company with no public stock price. No recent secondary market data is available.

How much is Keliomics worth (valuation)?

Valuation information for Keliomics is not publicly available.

Can I buy Keliomics stock?

Keliomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Keliomics's last funding round?

Funding round information for Keliomics is not publicly available.

Who are the main investors in Keliomics?

Investor information for Keliomics is not publicly disclosed.

Will Keliomics IPO soon?

No public IPO plans have been announced for Keliomics.

How can I track Keliomics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Keliomics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew Orleans, Louisiana
Employee Range4
Year Founded2021
Last FundingJan 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?